TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

Videos | Structural Heart Occluders | November 08, 2017
VIDEO: How Transcatheter PFO Closure Can Reduce Cryptogenic Stroke
John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the...
read more
Videos | Cath Lab | November 08, 2017
VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on...
read more
OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

Feature | Stents | November 08, 2017
OrbusNeich Combo Dual-therapy Stent Noninferior Vs. Xience Stent in HARMONEE Trial
November 8, 2017 – New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report...
read more
FAVOR II Studies Examine Diagnostic Accuracy of Quantitative Flow Ratio, FFR-Angio.
News | FFR Technologies | November 08, 2017
FAVOR II Studies Examine Accuracy of Quantitative Flow Ratio FFR-Angiography
November 8, 2017 — Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their...
read more
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
News | Heart Valve Technology | November 08, 2017
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
November 8, 2017 —  Medtronic plc recently presented new clinical research to support the positive clinical performance...
read more
Videos | Heart Valve Technology | November 08, 2017
VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at...
read more
Videos | Heart Valve Technology | November 08, 2017
VIDEO: MAVERIC 6-month Outcomes for the Arto Mitral Valve Reshaping System
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the...
read more
Videos | Stents Bioresorbable | November 07, 2017
VIDEO: What Went Wrong With the Absorb Stent?
A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian...
read more
Harpoon Mitral Valve Repair System data reported at TCT 2017
Feature | Heart Valve Technology | November 07, 2017
Harpoon Device May Improve Quality, Frequency of Mitral Repair
November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and can...
read more
Videos | Heart Valve Technology | November 07, 2017
VIDEO: Update of Mitral Valve Repair and Replacement Technologies
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of...
read more
Medtronic Unveils Strong Early Outcomes for Intrepid Transcatheter Mitral Valve Replacement System
News | Heart Valve Technology | November 07, 2017
Medtronic Unveils Strong Early Outcomes for Intrepid Transcatheter Mitral Valve Replacement System
November 7, 2017 — Medtronic plc recently presented positive data for its self-expanding Intrepid transcatheter mitral...
read more
Harpoon Mitral Valve Repair System Found Safe and Effective
News | Heart Valve Technology | November 07, 2017
Harpoon Mitral Valve Repair System Found Safe and Effective
November 7, 2017 — A new study has found that a pioneering device to repair heart valves is safe and effective, and can...
read more
HREVS study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, at TCT 2017.

Study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, explaining the HREVS trial results at TCT 2017.

News | November 06, 2017 | Dave Fornell
No Major Differences Between PCI vs. CABG vs. Hybrid Revascularization in HREVS Study
November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different...
read more
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
ORBITA Study Finds No Improvement in Exercise Time Over Placebo in PCI Patients
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found...
read more
Mitralign's Trialign system is used for transcatheter repair of tricuspid valve regurgitation. TCT 2017
News | Heart Valve Technology | November 06, 2017
Positive, Sustained Improvement at One Year in SCOUT I Transcatheter Tricuspid Repair Trial
November 6, 2017 — One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System...
read more
© Copyright Wainscot Media. All Rights Reserved.